Search research articles
Contact Us
Filters
Showing results (1241-1250 of 1,530) with videos related to
Page
of 153
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2000
Retinoic acid receptor-beta as a prognostic indicator in stage I non-small-cell lung cancer
F R Khuri, R Lotan, B L Kemp, et al.
Studies in Mycology
|
February 1, 2024
The subfamily <i>Xerocomoideae</i> (<i>Boletaceae</i>, <i>Boletales</i>) in China
R Xue, X Zhang, C Xu, et al.
Oncogene
|
August 27, 2013
p53 regulates mesenchymal stem cell-mediated tumor suppression in a tumor microenvironment through immune modulation
Y Huang, P Yu, W Li, et al.
Allergologia Et Immunopathologia
|
June 21, 2017
The safety profile of subcutaneous allergen immunotherapy in children with asthma in Hangzhou, East China
J-L Liu, W-X Ning, S-X Li, et al.
Oncogene
|
April 26, 2016
Type I interferons exert anti-tumor effect via reversing immunosuppression mediated by mesenchymal stromal cells
P Shou, Q Chen, J Jiang, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]
|
October 28, 2021
[Genomic investigation of human <i>Streptococcus suis</i> infection in Shandong Province]
B Hu, J P Wang, Y C Xu, et al.
Biological Psychiatry
|
March 10, 2001
Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder
C L Barr, C Xu, J Kroft, et al.
Acta Virologica
|
December 15, 2012
Trends in seroprevalence of antibodies to pandemic influenza H1N1 (2009) virus among patients seeking care in China
C Xu, T Bai, M Wang, et al.
JCO Clinical Cancer Informatics
|
April 11, 2025
Machine Learning Models of Early Longitudinal Toxicity Trajectories Predict Cetuximab Concentration and Metastatic Colorectal Cancer Survival in the Canadian Cancer Trials Group/AGITG CO.17/20 Trials
Danielle Lilly Nicholls, Maria C Xu, Luna Zhan, et al.
ESMO Open
|
March 18, 2026
Phase III trial of infigratinib versus gemcitabine/cisplatin in adults with advanced cholangiocarcinoma with FGFR2 gene fusion or rearrangement: results and reflections on early termination of PROOF 301
G K Abou-Alfa, I Borbath, S Roychowdhury, et al.
Page
of 153
Search research articles
Search
Showing results (1241-1250 of 1,530) with videos related to
Sort By:
Page
of 153
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2000
Retinoic acid receptor-beta as a prognostic indicator in stage I non-small-cell lung cancer
F R Khuri, R Lotan, B L Kemp, et al.
Studies in Mycology
|
February 1, 2024
The subfamily <i>Xerocomoideae</i> (<i>Boletaceae</i>, <i>Boletales</i>) in China
R Xue, X Zhang, C Xu, et al.
Oncogene
|
August 27, 2013
p53 regulates mesenchymal stem cell-mediated tumor suppression in a tumor microenvironment through immune modulation
Y Huang, P Yu, W Li, et al.
Allergologia Et Immunopathologia
|
June 21, 2017
The safety profile of subcutaneous allergen immunotherapy in children with asthma in Hangzhou, East China
J-L Liu, W-X Ning, S-X Li, et al.
Oncogene
|
April 26, 2016
Type I interferons exert anti-tumor effect via reversing immunosuppression mediated by mesenchymal stromal cells
P Shou, Q Chen, J Jiang, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]
|
October 28, 2021
[Genomic investigation of human <i>Streptococcus suis</i> infection in Shandong Province]
B Hu, J P Wang, Y C Xu, et al.
Biological Psychiatry
|
March 10, 2001
Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder
C L Barr, C Xu, J Kroft, et al.
Acta Virologica
|
December 15, 2012
Trends in seroprevalence of antibodies to pandemic influenza H1N1 (2009) virus among patients seeking care in China
C Xu, T Bai, M Wang, et al.
JCO Clinical Cancer Informatics
|
April 11, 2025
Machine Learning Models of Early Longitudinal Toxicity Trajectories Predict Cetuximab Concentration and Metastatic Colorectal Cancer Survival in the Canadian Cancer Trials Group/AGITG CO.17/20 Trials
Danielle Lilly Nicholls, Maria C Xu, Luna Zhan, et al.
ESMO Open
|
March 18, 2026
Phase III trial of infigratinib versus gemcitabine/cisplatin in adults with advanced cholangiocarcinoma with FGFR2 gene fusion or rearrangement: results and reflections on early termination of PROOF 301
G K Abou-Alfa, I Borbath, S Roychowdhury, et al.
Page
of 153